1aksim Training and Research Hospital, Istanbul, Turkey
2Private Öz Istanbul Medical Center, Istanbul, Turkey
3Department of Internal Medicine, Abant İzzet Baysal University, Bolu, Turkey
Received Date: April 14, 2017; Accepted Date: August 24, 2017; Published Date: August 31, 2017
Citation: Celebi A, Akdemir F, Gurler M, Koc DO, Ozdemir AA, et al. (2017) A Retrospective Analysis of Esophagogastroduodenoscopies: A Single Center Experience. J Gastrointest Dig Syst 7:521. doi:10.4172/2161-069X.1000521
Copyright: © 2017 Celebi A, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Visit for more related articles at Journal of Gastrointestinal & Digestive System
Goals: To present retrospective data on esophagogastroduodenoscopy (EGD) findings of patients who were admitted to a training and research hospital due to upper gastrointestinal system problems.
Background: EGD is an interventional method used for diagnosing diseases of the esophagus, stomach, and duodenum. EGD is essential in the diagnosis of various benign and malign upper gastrointestinal diseases, as well as for therapy or disease follow-up.
Study: This study evaluated retrospective data of 5014 patients with upper gastrointestinal problems who were admitted to General Surgery and Family Medicine Departments and Emergency Service of Taksim Training and Research Hospital and were referred for EGD in the Endoscopy Department between the years 2002 and 2009.
Results: Among 5014 patients, EGD could be performed in 4950 (2820 females) with a mean age of 47.7 ± 16.2 years (range, 31.5-63.9 years). The number of patients undergoing EGD was higher in 2007 and 2008 than the other years. The most common diagnosis was gastric diseases (92.1%). Only 3.3% of all patients had normal EGD findings. Gastritis, hiatal insufficiency, and duodenitis were the most common diseases in the study population (84.3%, 24.4%, and 10.6% respectively). Esophageal, gastric, and duodenal diseases were most commonly observed in the years 2007 and 2008 in the whole study population.
Conclusion: Our study revealed that gastric diseases were the most commonly observed diseases in the patients undergoing EGD. Endoscopy is a safe and reliable procedure that is essential for the diagnosis, treatment and follow-up of upper gastrointestinal diseases.
Esophagogastroduodenoscopy; Endoscopy; Gastritis; Duodenitis; Hiatal insufficiency
Gastrointestinal system (GIS) diseases are one of the most common healthcare issues worldwide [1-4]. Currently, endoscopy is most commonly used for visualization of the interior surfaces of the GIS [5]. The continuous development of gastrointestinal endoscopic devices in response to the requirement for more detailed images has recently resulted in the advancement of previous devices with limited capacity to flexible, physician friendly and computerized equipment [6].
Today, esophagogastroduodenoscopy (EGD) is the standardized endoscopic imaging method employed for diagnosis of the diseases of the esophagus, stomach, and duodenum in daily medical practice. In addition to its routine use for the diagnosis of various benign and malignant upper gastrointestinal diseases, GIS endoscopy in some special occasions may also be required for the treatment and follow-up of some certain diseases (Table 1).
Diagnostic indications | Therapeutic indications | Follow-up indications |
---|---|---|
Follow-up and therapy of dyspeptic disease | GIS bleeding secondary to/as a result of ulcer | Familial adenomatous polyposis syndromes |
Anorexia | GIS bleeding secondary to cancer | Barrett’s esophagus |
Gastrointestinal symptoms in patients ≥45 years old | GIS bleeding secondary to vascular abnormalities | Premalignant conditions |
Dysphagia/odynophagia | Gastrointestinal varices | |
Esophageal reflux | Removal of polypoid lesions | |
Idiopathic vomiting | Dilatations of lesions that cause stenosis | |
Neoplasms that lead to stenosis |
Table 1: Endoscopic applications in the upper gastrointestinal system. [GIS: Gastrointestinal system].
Although upper GIS endoscopy is a useful tool for diagnosis, therapy, and follow-up, there are some limiting conditions for its use. Besides, endoscopic interventions are also associated with some adverse effects, such as perforation, hemorrhage, cardiac arrhythmias, aspiration, and even Mallory-Weiss tears [7].
The use of sedatives and topical anesthetics may also lead to cardiac and respiratory complications as well as adverse drug interactions especially in patients with underlying cardiorespiratory diseases [8]. On the other hand, the safety of diagnostic EGD is much higher than that of therapeutic EGD, as the overall incidence of all complications in EGD is estimated as 0.1% [9,10].
The aim of the present study was to present retrospective data on EGD findings of patients who were admitted to a training and research hospital due to upper GIS problems.
The present study analyzed the retrospective data from 2002 through 2009 of 5014 patients with upper gastrointestinal problems. The patients were admitted to the General Surgery and Family Medicine Departments and Emergency Service of Taksim Training and Research Hospital and were referred for EGD in the Endoscopy Department. The frequency and distribution of upper gastrointestinal findings were evaluated. Written informed consents of the patients were obtained. Descriptive statistics were expressed as mean, standard deviation, minimum and maximum for numerical variables and as number and percentage for categorical variables, where appropriate.
Among 5014 patients, EGD could be performed in 4950 with a mean age of 47.7 ± 16.2 years (range, 31.5-63.9 years). Sixty-four patients were excluded from the study since EGD could not be performed due to various patient-related conditions. Of 4950 patients, 2130 were male with a mean age of 48.8 ± 16.62 years and 2820 were female with a mean age of 49.9 ± 15.82 years. Data revealed that the number of patients undergoing EGD was higher in 2007 and 2008 than the other years (Table 2).
Years | Gender n (%) | Total n (%) | |
---|---|---|---|
Female | Male | ||
2002 | 258 (65.2) | 138 (34.8) | 396 (8.0) |
2003 | 224 (62.7) | 133 (37.3) | 357 (7.2) |
2004 | 110 (57.3) | 82 (42.7) | 192 (3.9) |
2005 | 32 (51.6) | 30 (48.4) | 62 (1.4) |
2006 | 351 (53.1) | 310 (46.9) | 661 (13.4) |
2007 | 958 (56.1) | 750 (43.9) | 1708 (34.5) |
2008 | 883 (56.5) | 679 (43.5) | 1562 (31.6) |
2009 | 4 (33.3) | 8 (66.7) | 12 (0.2) |
Total | 2820 (57.0) | 2130 (43.0) | 4950 (100.0) |
Table 2: Distribution of patients according to years.
The most common diagnosis was gastric diseases, followed by esophageal diseases and duodenal diseases in the whole study population (Table 3). Only 3.3% of all patients had normal EGD findings (Table 4). The distribution of gastric, esophageal, and duodenal findings in the study population and according to gender are presented in Table 5.
Gender n(%) | Total n(%) | ||
---|---|---|---|
Female | Male | ||
Esophageal diseases | 770 (48.6) | 813 (51.4) | 1583 (32.0) |
Gastric diseases | 2590 (56.8) | 1967 (43.2) | 4557 (92.1) |
Duodenal diseases | 434 (47.5) | 480 (52.5) | 914 (18.5) |
Table 3: Distribution of diagnosis in the study population and according to gender.
EGD Findings | Gender n(%) | Total n(%) | |
---|---|---|---|
Female | Male | ||
Normal | 109 (66.5) | 55 (33.5) | 164 (3.3) |
Pathologic | 2711 (56.6) | 2075 (43.4) | 4786 (96.7) |
Total | 2820 (57.0) | 2130 (43.0) | 4950 (100.0) |
Table 4: Distribution of esophagogastroduodenoscopy findings in the study population and according to gender. [EGD: Esophagogastroduodenoscopy].
EGD Findings | Gender n(%) | All patients n(%) | ||
Gastric | Female | Male | With gastric diseases n=4557 | In the study n=4950 |
Gastritis | 2415 (57.8) | 1760 (42.2) | 4175 (91.6) | 4175 (84.3) |
Cancer | 116 (47.5) | 128 (52.5) | 244 (5.4) | 244 (4.9) |
Ulcer | 251 (46.1) | 293 (53.9) | 544 (11.9) | 544 (11) |
Bleeding | 2 (16.7) | 10 (83.3) | 12 (0.3) | 12 (0.2) |
Other gastric diseases | 139 (47.3) | 155 (52.7) | 294 (6.5) | 294 (5.9) |
Esophageal | Female | Male | With esophageal diseases n=1583 | In the study n=4950 |
Hiatal insufficiency | 595 (49.3) | 612 (50.7) | 1207 (76.2%) | 1207 (24.4) |
Esophageal ulcer | 7 (41.2) | 10 (58.8) | 17 (1.1%) | 17 (0.3) |
Esophagitis | 336 (46.7) | 384 (53.3) | 720 (45.5%) | 720 (14.5) |
Esophagealvarices | 13 (31.0) | 29 (69.0) | 42 (2.7%) | 42 (0.8) |
Esophagealtumors | 17 (44.7) | 21 (55.3) | 38 (2.4%) | 38 (0.8) |
Barrett’s esophagus | 18 (39.1) | 28 (60.9) | 46 (2.9%) | 46 (0.9) |
Other esophageal diseases | 20 (48.8) | 21 (51.2) | 41 (2.6%) | 41 (0.8) |
Duodenal | Female | Male | With duodenal diseases n=914 | In the study population n=4950 |
Duodenitis | 255 (48.6) | 270 (51.4) | 525 (57.4) | 525 (10.6) |
Active duodenal ulcer | 114 (39.3) | 176 (60.7) | 290 (31.7) | 290 (5.9) |
Duodenal malformations | 6 (35.3) | 11 (64.7) | 17 (1.9) | 17 (0.3) |
Tumor | 11 (73.3) | 4 (26.7) | 15 (1.6) | 15 (0.3) |
Duodenogastric reflux | 67 (58.8) | 47 (41.2) | 114 (12.5) | 114 (2.3) |
Other duodenal diseases | 5 (23.8) | 16 (76.2) | 21 (2.3) | 21 (0.4) |
Table 5: Distribution of gastric, esophageal, and duodenal findings in the study population and according to gender. [EGD: Esophagogastroduodenoscopy].
Gastritis, hiatal insufficiency, and duodenitis were the most common diseases in the patients with gastric, esophageal, and duodenal findings, respectively, as well as within the study population. The distributions of esophageal, gastric, and duodenal diseases according to years and gender are summarized in Table 6. Esophageal, gastric, and duodenal diseases were most commonly observed in the years 2007 and 2008 in the whole study population.
Diseases | Years | Gender n (%) | Total within disease n (%) | |
---|---|---|---|---|
Female | Male | |||
Esophageal Diseases n=1583 | 2002 | 24 (63.2) | 14 (36.8) | 38 (2.4) |
2003 | 32 (64.0) | 18 (36.0) | 50 (3.2) | |
2004 | 17 (50.0) | 17 (50.0) | 34 (2.1) | |
2005 | 2 (50.0) | 2 (50.0) | 4 (0.3) | |
2006 | 118 (44.5) | 147 (55.5) | 265 (16.7) | |
2007 | 296 (47.2) | 331 (52.8) | 627 (39.6) | |
2008 | 281 (50.1) | 280 (49.9) | 561 (35.4) | |
2009 | 0 (0.0) | 4 (100.0) | 4 (0.3) | |
Gastric Diseases n=4557 | 2002 | 237 (64.9) | 128 (35.1) | 365 (8.0) |
2003 | 204 (62.8) | 121 (37.2) | 325 (7.1) | |
2004 | 100 (57.1) | 75 (42.9) | 175 (3.8) | |
2005 | 29 (51.8) | 27 (48.2) | 56 (1.2) | |
2006 | 333 (54.1) | 282 (45.9) | 615 (13.5) | |
2007 | 882 (55.8) | 700 (44.2) | 1582 (34.7) | |
2008 | 801 (56.1) | 628 (43.9) | 1429 (31.4) | |
2009 | 4 (40.0) | 6 (60.0) | 10 (0.2) | |
Duodenal Diseases n=914 | 2002 | 27 (58.7) | 19 (41.3) | 46 (5.0) |
2003 | 35 (59.3) | 24 (40.7) | 59 (6.5) | |
2004 | 14 (45.2) | 17 (54.8) | 31 (3.4) | |
2005 | 2 (50.0) | 2 (50.0) | 4 (0.4) | |
2006 | 80 (44.4) | 100 (55.6) | 180 (19.7) | |
2007 | 151 (44.0) | 192 (56.0) | 343 (37.5) | |
2008 | 123 (49.8) | 124(50.2) | 247 (27.0) | |
2009 | 2 (50.0) | 2 (50.0) | 4 (0.4) |
Table 6: Distributions of esophageal, gastric, and duodenal diseases according to years and gender.
In addition to being one of the most common healthcare issues worldwide, diseases of the GIS are continuously increasing and thereby GIS endoscopy has become one of the most common endoscopic procedures recently. The present study aimed to present retrospective data on EGD findings of patients with upper GIS problems.
Previous reports have been suggested that esophageal, gastric, and duodenal pathologies are remarkably frequent. In a study from Sudan, the incidences of the diseases of esophagus, stomach, and duodenum were reported as 24%, 10%, and 14%, respectively [11]. In the present study, at least one pathology was identified in EGD examination of 4950 patients and the rates of esophageal, gastric, and duodenal diseases were 32%, 92.1%, and 18.5%, respectively. Similarly, gastric diseases have been reported as the most frequent gastrointestinal diseases in Ghana [12]. On the other hand, a study from China, in which data from patients were recorded between 2000 and 2011, reported that the frequency of Barrett’s esophagus was 1.0% [13]. However, our study, which comprised patient data from 2002 to 2009, found the frequency of Barrett’s esophagus to be 0.9%.
Upper gastrointestinal endoscopy carries a risk of perforation in approximately 0.03% [14]. Bacteremia is a rare complication of endoscopy and it is even less common in upper endoscopy [15]. The total risk for all complications is 1 in 5000 patients [9]. One earlier report from 1974, which included EGD data of 211410 patients, indicated that the rate for all complications was 0.13% and mortality rate was 0.004% [16]. The decrease in the complication rates might mainly be due to the improvements in imaging techniques and software and to the development of the equipment.
Surgical treatment is a common treatment of choice for esophageal cancers despite high perioperative mortality and morbidity rates [17,18]. However, endoscopic resection is a safe and effective option for the treatment of superficial esophageal cancers without any lymph node metastasis [19]. Moreover, endoscopy is also beneficial in staging of malignancies and in decision of treatment protocols [20].
In the present study, there were 38 patients with esophageal tumors (2.4% within all patients with any esophageal finding and 0.8% within all patients), 244 patients with gastric tumors (5.4% within all patients with any gastric finding and 4.9% within all patients), and 15 patients with duodenal tumors (1.6% within all patients with any duodenal finding and 0.3% within all patients). Therefore, this study revealed that approximately 6% of all endoscopic examinations were performed in malignancies with different stages, which highlighted the importance of the diagnostic use of endoscopy.
In conclusion, when complication results are evaluated, it should be taken into account that long follow-up has not been performed since the study was retrospectively separated from the endoscopy unit of the patient. Later complications could not be documanted. Endoscopy is a safe and reliable procedure that is essential for the diagnosis, treatment, and follow-up of upper gastrointestinal diseases.
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals